Hyperhomocysteinemia is a known risk factor for thrombosis in both adults and children. Mutations of genes encoding the enzymes in homocysteine metabolism are predicted to cause elevation of homocysteine and increase the risk of thrombosis. Therefore, this study objectives are to determine the prevalence of methylenetetrahydrofolate reductase (MTHFR) 677C->T, 1298A->C; methionine synthase (MS) 2756A->G, and cystathione β-synthase (CBS) 884ins68 in Thai ethnic patients, aged ≤18 years, and their relationship to thrombosis. The population consisted of 91 patients, from 2 medical institutes in Thailand, first diagnosed with thrombosis. The control group was 169 healthy, Thai children matched for age (mean ± SD in cases/controls = 9.4 ± 5.7 / 9.3 ± 5.7 years, p = 0.9) and sex (male/female in cases/controls = 57.1%/42.9%/53.8%/46.2%, p = 0.7). Genotyping was performed using standard PCR/restriction enzyme assays. The prevalence and allele frequency of the genes are shown in Table 1. The polymorphisms of individual genes and the combinations between the genotype did not affect plasma homocysteine level. The details are shown in Table 2. Conclusion, the prevalence of MTHFR 677C->T, 1298A->C, MS 2756A->G, and CBS 884ins68 in Thai population was lower than Caucasian population; and did not cause the increase risk for thrombosis in Thai children.
Table 1. Frequency of genetic polymorphisms between patients and controls.
MTHFR 677A
. | CC (%)
. | CT (%)
. | TT (%)
. | T frequency (%)
. |
---|
Controls | 71.8 | 27 | 1.2 | 14.7 |
Patients | 73.5 | 25.3 | 1.2 | - |
p-value | - | 0.91 | 0.96 | - |
MTHFR 1298 | AA (%) | AC (%) | CC (%) | C frequency (%) |
Controls | 50.0 | 42.1 | 7.9 | 24.4 |
Patients | 54.3 | 42.0 | 3.7 | - |
p-value | - | 0.76 | 0.26 | - |
MS 2756 | AA (%) | AG (%) | GG (%) | G frequency (%) |
Controls | 78.9 | 21.1 | 0 | 10.5 |
Patients | 75.9 | 24.1 | 0 | - |
p-value | - | 0.63 | - | - |
CBS 884ins68 | NN (%) | NI (%) | II (%) | G frequency (%) |
Controls | 98.7 | 0.6 | 0.6 | 1 |
Patients | 98.7 | 1.3 | 0 | - |
p-value | - | 0.55 | - | - |
MTHFR 677A
. | CC (%)
. | CT (%)
. | TT (%)
. | T frequency (%)
. |
---|
Controls | 71.8 | 27 | 1.2 | 14.7 |
Patients | 73.5 | 25.3 | 1.2 | - |
p-value | - | 0.91 | 0.96 | - |
MTHFR 1298 | AA (%) | AC (%) | CC (%) | C frequency (%) |
Controls | 50.0 | 42.1 | 7.9 | 24.4 |
Patients | 54.3 | 42.0 | 3.7 | - |
p-value | - | 0.76 | 0.26 | - |
MS 2756 | AA (%) | AG (%) | GG (%) | G frequency (%) |
Controls | 78.9 | 21.1 | 0 | 10.5 |
Patients | 75.9 | 24.1 | 0 | - |
p-value | - | 0.63 | - | - |
CBS 884ins68 | NN (%) | NI (%) | II (%) | G frequency (%) |
Controls | 98.7 | 0.6 | 0.6 | 1 |
Patients | 98.7 | 1.3 | 0 | - |
p-value | - | 0.55 | - | - |
Table 2. Homocysteine value and genetic polymorphisms.
Genetic polymorphism (number)
. | Plasma Hcy (μmol/L)
. | p value
. |
---|
MTHFR 677 |
CC (n=105) | 7.4 ± 2.9 | 0.11 |
CT (n=29) | 8.3 ± 2.7 | |
MTHFR 1298 |
AA (n=64) | 7.4 ± 2.4 | > 0.05 |
AC (n=59) | 7.5 ± 2.8 | > 0.05 |
CC (n=12) | 8.7 ± 5 | |
MS 2756 |
AA (n=110) | 7.8 ± 3 | |
AG (n=25) | 6.7 ± 1.9 | 0.055 |
CBS 884 ins 68 |
DD (n=137) | 7.5 ± 2.8 | |
ID (n=2) | 10.3 ± 8.7 | 0.72 |
MTHFR 677 / MTHFR 1298 |
CT/AC (n=16) | 8.7 ± 2.5 | 0.07 |
MTHFR 1298 / MS 2765 |
AC/AG (n=6)6.8 ± 1.6 | 6.8 ± 1.6 | 0.38 |
MTHFR 1298 / CBS884ins68 |
AC/IN (n=9) | 6.8 ± 2.1 | 0.34 |
Genetic polymorphism (number)
. | Plasma Hcy (μmol/L)
. | p value
. |
---|
MTHFR 677 |
CC (n=105) | 7.4 ± 2.9 | 0.11 |
CT (n=29) | 8.3 ± 2.7 | |
MTHFR 1298 |
AA (n=64) | 7.4 ± 2.4 | > 0.05 |
AC (n=59) | 7.5 ± 2.8 | > 0.05 |
CC (n=12) | 8.7 ± 5 | |
MS 2756 |
AA (n=110) | 7.8 ± 3 | |
AG (n=25) | 6.7 ± 1.9 | 0.055 |
CBS 884 ins 68 |
DD (n=137) | 7.5 ± 2.8 | |
ID (n=2) | 10.3 ± 8.7 | 0.72 |
MTHFR 677 / MTHFR 1298 |
CT/AC (n=16) | 8.7 ± 2.5 | 0.07 |
MTHFR 1298 / MS 2765 |
AC/AG (n=6)6.8 ± 1.6 | 6.8 ± 1.6 | 0.38 |
MTHFR 1298 / CBS884ins68 |
AC/IN (n=9) | 6.8 ± 2.1 | 0.34 |
Disclosure: No relevant conflicts of interest to declare.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal